Abstract
Human blood group polymorphisms are known to be determined by the expression of A, B or H antigens and the Lewis antigens. Protection against microbial infections has been associated with inheritance of polymorphisms in genes encoding and regulating the expression of ABH and Lewis antigens in bodily secretions and epithelial tissue surfaces, subsequently resulting in the presentation of different glycosylated terminal antigens on the cell surface. We investigated the role of blood group antigens in diversifying the glycosylation of buccal epithelial cells (BEC) that line the oral cavity. Specifically, we characterized and statistically evaluated the expression of histo-blood group (A, B, O) antigens on N-and O-linked glycans from BEC membrane proteins of various individuals that represented different blood group type and secretor status using a porous graphitic carbon liquid chromatography electrospray ionization mass spectrometry (PGC-LC-ESI-MS) based glycomics approach. From these BEC membrane proteins a total of 77 N-glycan and 96 O-glycan structures were structurally characterized from 19 individuals and relatively quantitated. The N-glycans from the secretor individuals did not express any A/B blood group determinants, but contained several terminal H-antigens. Apart from the non-secretors, the N-glycan profiles of BEC from all blood groups displayed similar glycan types, while varying in their relative intensities between individuals. However, multivariate analysis of the O-glycans from individuals displayed segregation patterns clearly associated with their blood group type and secretor status. In adhesion assays the oral pathogen Candida albicans showed a significantly higher interaction to blood group O type BECs relative to other blood groups.
Similar content being viewed by others
References
Anstee D.J.: The relationship between blood groups and disease. Blood. 115(23), 4635–4643 (2010). doi:10.1182/blood-2010-01-261859
Ravn V., Dabelsteen E.: Tissue distribution of histo-blood group antigens. APMIS. 108(1), 1–28 (2000)
Yamamoto F.: Review: ABO blood group system--ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. Immunohematology. 20(1), 3–22 (2004)
Oriol R., Le Pendu J., Mollicone R.: Genetics of ABO, H. Lewis, X and related antigens. Vox Sang. 51(3), 161–171 (1986)
Yamamoto F., Clausen H., White T., Marken J., Hakomori S.: Molecular genetic basis of the histo-blood group ABO system. Nature. 345(6272), 229–233 (1990). doi:10.1038/345229a0
Oriol R., Danilovs J., Hawkins B.R.: A new genetic model proposing that the Se gene is a structural gene closely linked to the H gene. Am. J. Hum. Genet. 33(3), 421–431 (1981)
Oriol R., Le Pendu J., Mollicone R.: Genetics of ABO, H. Lewis, X and related antigens. Vox Sang. 51(3), 161–171 (1986)
Yamamoto F., Hakomori S.: Sugar-nucleotide donor specificity of histo-blood group A and B transferases is based on amino acid substitutions. J. Biol. Chem. 265(31), 19257–19262 (1990)
Kermarrec N., Roubinet F., Apoil P.A., Blancher A.: Comparison of allele O sequences of the human and non-human primate ABO system. Immunogenetics. 49(6), 517–526 (1999)
Yunis E.J., Svardal J.M., Bridges R.A.: Genetics of the Bombay phenotype. Blood. 33(1), 124–132 (1969)
Marionneau S., Cailleau-Thomas A., Rocher J., Le Moullac-Vaidye B., Ruvoen N., Clement M., Le Pendu J.: ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie. 83(7), 565–573 (2001)
Blumenfeld O.O., Patnaik S.K.: Allelic genes of blood group antigens: a source of human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation Database. Hum. Mutat. 23(1), 8–16 (2004). doi:10.1002/humu.10296
Storry J.R., Olsson M.L.: The ABO blood group system revisited: a review and update. Immunohematology. 25(2), 48–59 (2009)
Greenwell P.: Blood group antigens: molecules seeking a function? Glycoconj. J. 14(2), 159–173 (1997)
Soejima M., Koda Y.: Molecular mechanisms of Lewis antigen expression. Leg Med (Tokyo). 7(4), 266–269 (2005). doi:10.1016/j.legalmed.2004.12.003
Henry S.M., Oriol R., Samuelsson B.E.: Expression of Lewis histo-blood group glycolipids in the plasma of individuals of Le(a + b+) and partial secretor phenotypes. Glycoconj. J. 11(6), 593–599 (1994)
Seymour R.M., Allan M.J., Pomiankowski A., Gustafsson K.: Evolution of the human ABO polymorphism by two complementary selective pressures. Proc. Biol. Sci. 271(1543), 1065–1072 (2004). doi:10.1098/rspb.2004.2674
Gagneux P., Varki A.: Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology. 9(8), 747–755 (1999)
Ilver D., Arnqvist A., Ogren J., Frick I.M., Kersulyte D., Incecik E.T., Berg D.E., Covacci A., Engstrand L., Boren T.: Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science. 279(5349), 373–377 (1998)
Kanbay M., Gur G., Arslan H., Yilmaz U., Boyacioglu S.: The relationship of ABO blood group, age, gender, smoking, and Helicobacter pylori infection. Dig. Dis. Sci. 50(7), 1214–1217 (2005)
Boren T., Falk P., Roth K.A., Larson G., Normark S.: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science. 262(5141), 1892–1895 (1993)
Aspholm M., Kalia A., Ruhl S., Schedin S., Arnqvist A., Linden S., Sjostrom R., Gerhard M., Semino-Mora C., Dubois A., Unemo M., Danielsson D., Teneberg S., Lee W.K., Berg D.E., Boren T.: Helicobacter pylori adhesion to carbohydrates. Methods Enzymol. 417, 293–339 (2006). doi:10.1016/S0076-6879(06)17020-2
Linden S., Nordman H., Hedenbro J., Hurtig M., Boren T., Carlstedt I.: Strain- and blood group-dependent binding of Helicobacter pylori to human gastric MUC5AC glycoforms. Gastroenterology. 123(6), 1923–1930 (2002). doi:10.1053/gast.2002.37076
Marionneau S., Airaud F., Bovin N.V., Le Pendu J., Ruvoen-Clouet N.: Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J Infect Dis. 192(6), 1071–1077 (2005). doi:10.1086/432546
Huang P., Farkas T., Marionneau S., Zhong W., Ruvoen-Clouet N., Morrow A.L., Altaye M., Pickering L.K., Newburg D.S., LePendu J., Jiang X.: Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis. 188(1), 19–31 (2003). doi:10.1086/375742
Huang P., Farkas T., Zhong W., Tan M., Thornton S., Morrow A.L., Jiang X.: Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 79(11), 6714–6722 (2005). doi:10.1128/JVI.79.11.6714-6722.2005
Nilsson J., Rydell G.E., Le Pendu J., Larson G.: Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids. Glycoconjugate Journal. 26(9), 1171–1180 (2009). doi:10.1007/s10719-009-9237-x
Hutson A.M., Atmar R.L., Graham D.Y., Estes M.K.: Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis. 185(9), 1335–1337 (2002). doi:10.1086/339883
Shirato H., Ogawa S., Ito H., Sato T., Kameyama A., Narimatsu H., Xiaofan Z., Miyamura T., Wakita T., Ishii K., Takeda N.: Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J. Virol. 82(21), 10756–10767 (2008). doi:10.1128/JVI.00802-08
Blackwell C.C., Jonsdottir K., Hanson M.F., Weir D.M.: Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet. 2(8508), 687 (1986)
Blackwell C.C., Jonsdottir K., Hanson M., Todd W.T., Chaudhuri A.K., Mathew B., Brettle R.P., Weir D.M.: Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet. 2(8501), 284–285 (1986)
Sheinfeld J., Schaeffer A.J., Cordon-Cardo C., Rogatko A., Fair W.R.: Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N. Engl. J. Med. 320(12), 773–777 (1989). doi:10.1056/NEJM198903233201205
Taylor-Cousar J.L., Zariwala M.A., Burch L.H., Pace R.G., Drumm M.L., Calloway H., Fan H., Weston B.W., Wright F.A., Knowles M.R.: Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity. PLoS One. 4(1), e4270 (2009). doi:10.1371/journal.pone.0004270
Cannon R.D., Chaffin W.L.: Oral colonization by Candida albicans. Crit. Rev. Oral Biol. Med. 10(3), 359–383 (1999)
Thom S.M., Blackwell C.C., MacCallum C.J., Weir D.M., Brettle R.P., Kinane D.F., Wray D.: Non-secretion of blood group antigens and susceptibility to infection by Candida species. FEMS Microbiol. Immunol. 1(6–7), 401–405 (1989)
Ben-Aryeh H., Blumfield E., Szargel R., Laufer D., Berdicevsky I.: Oral Candida carriage and blood group antigen secretor status. Mycoses. 38(9–10), 355–358 (1995)
Burford-Mason A.P., Weber J.C., Willoughby J.M.: Oral carriage of Candida albicans, ABO blood group and secretor status in healthy subjects. J Med Vet Mycol. 26(1), 49–56 (1988)
Shin E.S., Chung S.C., Kim Y.K., Lee S.W., Kho H.S.: The relationship between oral Candida carriage and the secretor status of blood group antigens in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 96(1), 48–53 (2003). doi:10.1067/moe.2003.S1079210403001604
Brassart D., Woltz A., Golliard M., Neeser J.R.: In vitro inhibition of adhesion of Candida albicans clinical isolates to human buccal epithelial cells by Fuc alpha 1----2Gal beta-bearing complex carbohydrates. Infect. Immun. 59(5), 1605–1613 (1991)
Johansson I., Bratt P., Hay D.I., Schluckebier S., Stromberg N.: Adhesion of Candida albicans, but not Candida krusei, to salivary statherin and mimicking host molecules. Oral Microbiol. Immunol. 15(2), 112–118 (2000)
Critchley I.A., Douglas L.J.: Role of glycosides as epithelial cell receptors for Candida albicans. J. Gen. Microbiol. 133(3), 637–643 (1987)
Yu L., Lee K.K., Sheth H.B., Lane-Bell P., Srivastava G., Hindsgaul O., Paranchych W., Hodges R.S., Irvin R.T.: Fimbria-mediated adherence of Candida albicans to glycosphingolipid receptors on human buccal epithelial cells. Infect. Immun. 62(7), 2843–2848 (1994)
Everest-Dass A.V., Jin D., Thaysen-Andersen M., Nevalainen H., Kolarich D., Packer N.H.: Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans. Glycobiology. 22(11), 1465–1479 (2012). doi:10.1093/glycob/cws112
Xie H., Onsongo G., Popko J., de Jong E.P., Cao J., Carlis J.V., Griffin R.J., Rhodus N.L., Griffin T.J.: Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol. Cell. Proteomics. 7(3), 486–498 (2008). doi:10.1074/mcp.M700146-MCP200
Osswald K., Mittas A., Glei M., Pool-Zobel B.L.: New revival of an old biomarker: characterisation of buccal cells and determination of genetic damage in the isolated fraction of viable leucocytes. Mutat. Res. 544(2–3), 321–329 (2003)
Lee A., Kolarich D., Haynes P.A., Jensen P.H., Baker M.S., Packer N.H.: Rat liver membrane glycoproteome: enrichment by phase partitioning and glycoprotein capture. J. Proteome Res. 8(2), 770–781 (2009). doi:10.1021/pr800910w
Wilson N.L., Schulz B.L., Karlsson N.G., Packer N.H.: Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins. J. Proteome Res. 1(6), 521–529 (2002)
Jensen P.H., Karlsson N.G., Kolarich D., Packer N.H.: Structural analysis of N- and O-glycans released from glycoproteins. Nat. Protoc. 7(7), 1299–1310 (2012). doi:10.1038/nprot.2012.063
Bronner-Fraser M.: Alterations in neural crest migration by a monoclonal antibody that affects cell adhesion. J. Cell Biol. 101(2), 610–617 (1985)
Hodgkin P.D., Lee J.H., Lyons A.B.: B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 184(1), 277–281 (1996)
Daffertshofer A., Lamoth C.J., Meijer O.G., Beek P.J.: PCA in studying coordination and variability: a tutorial. Clin Biomech (Bristol, Avon). 19(4), 415–428 (2004). doi:10.1016/j.clinbiomech.2004.01.005
Ringner M.: What is principal component analysis? Nat. Biotechnol. 26(3), 303–304 (2008). doi:10.1038/nbt0308-303
Fumagalli M., Cagliani R., Pozzoli U., Riva S., Comi G.P., Menozzi G., Bresolin N., Sironi M.: Widespread balancing selection and pathogen-driven selection at blood group antigen genes. Genome Res. 19(2), 199–212 (2009). doi:10.1101/gr.082768.108
Ferrer-Admetlla A., Sikora M., Laayouni H., Esteve A., Roubinet F., Blancher A., Calafell F., Bertranpetit J., Casals F.: A natural history of FUT2 polymorphism in humans. Mol. Biol. Evol. 26(9), 1993–2003 (2009). doi:10.1093/molbev/msp108
Cameron B.J., Douglas L.J.: Blood group glycolipids as epithelial cell receptors for Candida albicans. Infect. Immun. 64(3), 891–896 (1996)
Chaffin W.L.: Candida albicans cell wall proteins. Microbiol. Mol. Biol. Rev. 72(3), 495–544 (2008). doi:10.1128/MMBR.00032-07
Donohue D.S., Ielasi F.S., Goossens K.V., Willaert R.G.: The N-terminal part of Als1 protein from Candida albicans specifically binds fucose-containing glycans. Mol. Microbiol. 80(6), 1667–1679 (2011). doi:10.1111/j.1365-2958.2011.07676.x
Zhu W., Filler S.G.: Interactions of Candida albicans with epithelial cells. Cell. Microbiol. 12(3), 273–282 (2010). doi:10.1111/j.1462-5822.2009.01412.x
Hoyer L.L., Green C.B., Oh S.H., Zhao X.: Discovering the secrets of the Candida albicans agglutinin-like sequence (ALS) gene family--a sticky pursuit. Medical mycology: official publication of the International Society for Human and Animal Mycology. 46(1), 1–15 (2008). doi:10.1080/13693780701435317
Murciano C., Moyes D.L., Runglall M., Tobouti P., Islam A., Hoyer L.L., Naglik J.R.: Evaluation of the role of Candida albicans agglutinin-like sequence (Als) proteins in human oral epithelial cell interactions. PLoS One. 7(3), e33362 (2012). doi:10.1371/journal.pone.0033362
Acknowledgments
NHP and AVE-D acknowledges the financial support of the ARC CoE in Nanoscale Biophotonics (ARC CE140100003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical approval
The saliva samples collected for this study were obtained ethically as approved by the University.
Electronic supplementary material
ESM 1 Figure S1
Representative CID-MS/MS fragment spectra derived from the singly charged negative ion O-linked glycans at m/z 10241− eluting at 27 min (A) and 31 min (B) respectively. The fragmentation of the structures was found to be consistent across different samples. Fragments are labelled according to the Domon and Costello (1988) scheme [1]. The identified structures with their key fragments are shown. (GIF 118 kb)
Rights and permissions
About this article
Cite this article
Everest-Dass, A.V., Kolarich, D., Pascovici, D. et al. Blood group antigen expression is involved in C. albicans interaction with buccal epithelial cells. Glycoconj J 34, 31–50 (2017). https://doi.org/10.1007/s10719-016-9726-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-016-9726-7